Topic picture, symbol photo: Corona vaccine. Pfizer and BioNTech Announce Successful First Interim Analysis of their COVID-19 Vaccine Candidate in Current Phase 3 Trial A hand wrapped in rubber gloves holds a disposable syringe of vaccine for injection in a needle BIONTECH biotechnology company. | usage worldwide
Germany’s COVID-19 vaccination campaign has been overshadowed by a mishap in the north where eight workers in an elderly care home received an overdose.
Vorpommern-Ruegen district authorities said the workers in Stralsund city received five times the recommended dose of the BioNTech-Pfizer vaccine on Sunday. Four went to the hospital for observation after developing flu-like symptoms.
“I deeply regret the incident. This individual case is due to individual errors. I hope that all those affected do not experience any serious side-effects,” district chief Stefan Kerth said in a statement.
The incident came after some German districts declined to use vaccines received over the weekend on suspicion that cold conditions were interrupted during delivery.
Vorpommern-Ruegen authorities pointed to previous statements by BioNtech saying larger doses were tested in the Phase 1 study without serious consequences. There was no immediate comment from the pharmaceutical companies.
(Reuters)
The official spokesperson for the Kasserine courts, Riadh Nouioui, confirmed today Wednesday that the prosecution…
Intelligence units of the National Guard district in Tunis, with the participation of central and…
Colombian President Gustavo Petro announced on Wednesday that his country will be cutting diplomatic ties…
Following the heavy sanction imposed on Tunisian sport by the World Anti-Doping Agency (WADA), the…
House speaker Ibrahim Bouderbala, confirmed yesterday Tuesday, while supervising the meeting of the Colloquium of Presidents…
Minister of Social Affairs, Malek Zahi, disclosed this Wednesday, on the sidelines of the May…
This website uses cookies.